Paret, C.; Lehmann, N.; Bender, H.; Sprang, M.; Sommer, C.J.; Cana, D.; Seidmann, L.; Wingerter, A.; Neu, M.A.; El Malki, K.;
et al. Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1. Cancers 2021, 13, 5838.
https://doi.org/10.3390/cancers13225838
AMA Style
Paret C, Lehmann N, Bender H, Sprang M, Sommer CJ, Cana D, Seidmann L, Wingerter A, Neu MA, El Malki K,
et al. Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1. Cancers. 2021; 13(22):5838.
https://doi.org/10.3390/cancers13225838
Chicago/Turabian Style
Paret, Claudia, Nadine Lehmann, Hannah Bender, Maximilian Sprang, Clemens J. Sommer, Denis Cana, Larissa Seidmann, Arthur Wingerter, Marie A. Neu, Khalifa El Malki,
and et al. 2021. "Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1" Cancers 13, no. 22: 5838.
https://doi.org/10.3390/cancers13225838
APA Style
Paret, C., Lehmann, N., Bender, H., Sprang, M., Sommer, C. J., Cana, D., Seidmann, L., Wingerter, A., Neu, M. A., El Malki, K., Alt, F., Roth, L., Marini, F., Ottenhausen, M., Glaser, M., Knuf, M., Russo, A., & Faber, J.
(2021). Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1. Cancers, 13(22), 5838.
https://doi.org/10.3390/cancers13225838